Oncolytic Viruses
This report offers a comprehensive analysis of the following key areas:
- Comprehensive Analysis: Detailed review of the Advanced Therapies landscape with over 12,000 assets tracked, including the development status of each.
- Abstract Review: In-depth analysis of preclinical, clinical, and trial outline abstracts.
- Therapeutic Modality Breakdown: Examination of therapeutic classes, diseases, and targets with a focus on solid tumors.
- Exclusive Insights: Overlap and interconnections between various Advanced Therapies.
Download Here
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Untitled-400-x-400-px-1.png)
Find out more
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies, combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape.
With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.